Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
10-year high
|
Strong Performer, Getting Expensive
746.0500
21.20
(
2.92
%)
NSE
Jul 01, 2025
15:57 PM
New 52W High today
Volume:
4.7M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
29 Jan 2022
10-year high
746.05
2.92%
Laurus Labs (HOLD): PAT declines 44% on negative operating leverage
Hold:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 570
Recommendation
Target
BOB Capital Markets Ltd.
Inventory destocking in ARV API/FDF led to 20% YoY decline in revenue; guided to normalise from Q4
Laurus Labs Ltd. has gained
21.63%
in the last 3 Months
More from Laurus Labs Ltd.
Recommended
Market closes flat, TVS Motor's total wholesales grow 20% YoY to 4 lakh units in June
Trendlyne Marketwatch |
01 Jul 2025, 03:53PM
IPOs This Week: Fifteen Upcoming Listings; Crizac Plus Eight New Issues
|
30 Jun 2025, 04:24PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020, 12:02PM